The Use of Human Acellular Dermal Matrix to Improve Infraauricular Depressed Deformities and Frey's Syndrome
Primary Purpose
Parotid Tumor
Status
Completed
Phase
Phase 3
Locations
China
Study Type
Interventional
Intervention
ADM
Sponsored by
About this trial
This is an interventional prevention trial for Parotid Tumor focused on measuring human acellular dermal matrix, parotid tumor, total parotidectomy
Eligibility Criteria
Inclusion Criteria:
- (1) a clinical and imaging diagnosis of either a malignant parotid tumor or deep parotid tumor
- (2) no previous surgical treatment
Exclusion Criteria:
- recurrent parotid tumors or patients who had previously undergone unsuccessful surgery
Sites / Locations
- West China Hospital of Stomatology
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
No Intervention
Arm Label
ADM group
control group
Arm Description
29 patients (ADM group) had a total parotidectomy with a simultaneous ADM implantation
41 patients (control group) had a total parotidectomy alone
Outcomes
Primary Outcome Measures
infraauricular depressed deformities and the presence of gustatory flushing or sweating
to explore whether human acellular dermal matrix (ADM) implantation could prevent infraauricular depressed deformities and Frey's syndrome following total parotidectomy
Secondary Outcome Measures
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT01414790
Brief Title
The Use of Human Acellular Dermal Matrix to Improve Infraauricular Depressed Deformities and Frey's Syndrome
Official Title
The Use of Human Acellular Dermal Matrix in the Prevention of Infraauricular Depressed Deformities and Frey's Syndrome Following Total Parotidectomy
Study Type
Interventional
2. Study Status
Record Verification Date
January 2011
Overall Recruitment Status
Completed
Study Start Date
January 2004 (undefined)
Primary Completion Date
January 2011 (Actual)
Study Completion Date
January 2011 (Actual)
3. Sponsor/Collaborators
Name of the Sponsor
West China Hospital
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
The aim of the study was to explore whether human acellular dermal matrix (ADM) implantation could prevent infraauricular depressed deformities and Frey's syndrome following total parotidectomy.
Detailed Description
Seventy patients who underwent total parotidectomy were selected for inclusion in the study. We analyzed 41 cases of total parotidectomy (control group) and 29 cases of simultaneous ADM implantation following total parotidectomy (ADM group) for infraauricular depressed deformities and the presence of gustatory flushing or sweating. The follow-up periods ranged from 6 months to 7 years.
The Results showed facial contours and bilateral symmetry improved after surgery in the ADM group. In the control group, an infraauricular depressed deformity was evident in all 41 cases. Frey's syndrome was recorded in one patient (3.4%) from the ADM group and 14 patients (34.1%) from the control group. No cases of immune rejection, infection, hematoma, or salivary fistula were observed in either group.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Parotid Tumor
Keywords
human acellular dermal matrix, parotid tumor, total parotidectomy
7. Study Design
Primary Purpose
Prevention
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
ParticipantOutcomes Assessor
Allocation
Randomized
Enrollment
70 (Actual)
8. Arms, Groups, and Interventions
Arm Title
ADM group
Arm Type
Experimental
Arm Description
29 patients (ADM group) had a total parotidectomy with a simultaneous ADM implantation
Arm Title
control group
Arm Type
No Intervention
Arm Description
41 patients (control group) had a total parotidectomy alone
Intervention Type
Procedure
Intervention Name(s)
ADM
Other Intervention Name(s)
Acellular dermal matrix
Intervention Description
29 patients (ADM group) had a total parotidectomy with a simultaneous ADM implantation
Primary Outcome Measure Information:
Title
infraauricular depressed deformities and the presence of gustatory flushing or sweating
Description
to explore whether human acellular dermal matrix (ADM) implantation could prevent infraauricular depressed deformities and Frey's syndrome following total parotidectomy
Time Frame
from 6 months to 7 years after surgery
10. Eligibility
Sex
All
Minimum Age & Unit of Time
10 Years
Maximum Age & Unit of Time
79 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
(1) a clinical and imaging diagnosis of either a malignant parotid tumor or deep parotid tumor
(2) no previous surgical treatment
Exclusion Criteria:
recurrent parotid tumors or patients who had previously undergone unsuccessful surgery
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Wen Luo, DMD
Organizational Affiliation
West China Hospital of Stomatology
Official's Role
Study Chair
Facility Information:
Facility Name
West China Hospital of Stomatology
City
Chengdu
State/Province
Sichuan
ZIP/Postal Code
610041
Country
China
12. IPD Sharing Statement
Citations:
PubMed Identifier
12533152
Citation
Sinha UK, Saadat D, Doherty CM, Rice DH. Use of AlloDerm implant to prevent frey syndrome after parotidectomy. Arch Facial Plast Surg. 2003 Jan-Feb;5(1):109-12. doi: 10.1001/archfaci.5.1.109.
Results Reference
result
Learn more about this trial
The Use of Human Acellular Dermal Matrix to Improve Infraauricular Depressed Deformities and Frey's Syndrome
We'll reach out to this number within 24 hrs